Two Sigma Securities’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-28,300
Closed -$1.87M 2147
2024
Q3
$1.87M Buy
28,300
+5,700
+25% +$414K 0.03% 573
2024
Q2
$2.09M Buy
22,600
+15,000
+197% +$1.33M 0.03% 693
2024
Q1
$726K Sell
7,600
-20,800
-73% -$1.75M 0.01% 1320
2023
Q4
$2.17M Buy
28,400
+19,800
+230% +$1.38M 0.02% 660
2023
Q3
$596K Buy
8,600
+700
+9% +$56.3K 0.01% 1407
2023
Q2
$745K Sell
7,900
-4,200
-35% -$365K 0.01% 1167
2023
Q1
$1M Buy
12,100
+4,200
+53% +$330K 0.02% 836
2022
Q4
$589K Buy
+7,900
New +$609K 0.02% 974
2022
Q2
Sell
-4,300
Closed -$506K 2399
2022
Q1
$506K Buy
+4,300
New +$482K 0.02% 1009
2021
Q1
Sell
-2,400
Closed -$219K 1116
2020
Q4
$219K Buy
+2,400
New +$199K 0.01% 1319
2020
Q2
Sell
-5,100
Closed -$321K 1458
2020
Q1
$321K Sell
5,100
-45,600
-90% -$3.29M 0.01% 816
2019
Q4
$3.94M Buy
50,700
+43,500
+604% +$3.4M 0.03% 483
2019
Q3
$528K Sell
7,200
-1,800
-20% -$126K ﹤0.01% 1186
2019
Q2
$554K Sell
9,000
-300
-3% -$18.1K 0.01% 1056
2019
Q1
$593K Buy
+9,300
New +$531K 0.01% 798
2018
Q4
Sell
-128,700
Closed -$7.47M 2338
2018
Q3
$7.47M Buy
128,700
+86,700
+206% +$4.24M 0.05% 275
2018
Q2
$2.04M Buy
42,000
+28,800
+218% +$1.34M 0.01% 915
2018
Q1
$614K Buy
+13,200
New +$573K ﹤0.01% 1542

Other funds holding EW

Two Sigma Securities's EW Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Edwards Lifesciences (EW) in Q1 2026: 4,637 shares worth $371K. The stake represents 0.04% of the portfolio and ranks #628 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in EW as recently as Q3 2025.

Two Sigma Securities first reported a position in EW in Q2 2016 and has held it in 18 quarters since. The position peaked at $3.19M in Q3 2018. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Two Sigma Securities held 4,637 shares of Edwards Lifesciences worth $371K as of Q1 2026.
  • Edwards Lifesciences was a new Two Sigma Securities position in Q1 2026.
  • Edwards Lifesciences made up 0.04% of Two Sigma Securities's portfolio in Q1 2026, its #628 holding.
  • Two Sigma Securities first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 18 quarters since.
  • Two Sigma Securities's Edwards Lifesciences position peaked at $3.19M in Q3 2018.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.